The costs of hospitalization in patients with acute exacerbation of chronic obstructive pulmonary disease

被引:28
作者
Ozkaya, Sevket [1 ]
Findik, Serhat [2 ]
Atici, Atilla Guven [2 ]
机构
[1] Rize Univ, Dept Pulm Med, Rize, Turkey
[2] Ondokuz Mayis Univ, Dept Pulm Med, Samsun, Turkey
关键词
COPD; acute exacerbation; hospitalization; costs;
D O I
10.2147/CEOR.S14820
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: Chronic obstructive pulmonary disease (COPD) is a major public health problem. It imparts a substantial economic burden on individuals and society. Acute exacerbations are the main cause of hospital admissions and hospitalizations in patients with COPD in Turkey. Objectives: We aimed to determine the costs of hospitalization in patients with acute exacerbations of COPD (AECOPD). Results: A total of 7832 (1556 women, 6276 men) patients were hospitalized due to acute exacerbations of COPD between 2005-2009 in the Samsun Chest Diseases and Thoracic Surgery Hospital, northern Turkey. The mean age was 64.6 +/- 19.8 years old and median length of hospital stay was 14.8 +/- 9.5 days. The mean cost per admission was US$718 +/- 364. Drug costs accounted for the largest portion (53.5%) of the mean cost, followed by bed cost (19.6%). One hundred seventy-four (2.2%) of the total hospitalized patients with AECOPD died in hospital. Conclusion: AECOPD continues to have both significant economic burden and high mortality rate.
引用
收藏
页码:15 / 18
页数:4
相关论文
共 19 条
[1]   The costs of exacerbations in chronic obstructive pulmonary disease (COPD) [J].
Andersson, F ;
Borg, S ;
Jansson, SA ;
Jonsson, AC ;
Ericsson, Å ;
Prütz, C ;
Rönmark, E ;
Lundbäck, B .
RESPIRATORY MEDICINE, 2002, 96 (09) :700-708
[2]   Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease [J].
Chen Ya-Hong ;
Yao Wan-Zhen ;
Cai Bai-Qiang ;
Wang Hong ;
Deng Xiao-Mei ;
Gao Hui-Li ;
Huang Jia-Sheng ;
Wang Xin-Mao .
CHINESE MEDICAL JOURNAL, 2008, 121 (07) :587-591
[3]   Outcomes following acute exacerbation of severe chronic obstructive lung disease [J].
Connors, AF ;
Dawson, NV ;
Thomas, C ;
Harrell, FE ;
Desbiens, N ;
Fulkerson, WJ ;
Kussin, P ;
Bellamy, P ;
Goldman, L ;
Knaus, WA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) :959-967
[4]   PREDICTING MORTALITY OF PATIENTS HOSPITALIZED FOR ACUTELY EXACERBATED CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
FUSO, L ;
INCALZI, RA ;
PISTELLI, R ;
MUZZOLON, R ;
VALENTE, S ;
PAGLIARI, G ;
GLIOZZI, F ;
CIAPPI, G .
AMERICAN JOURNAL OF MEDICINE, 1995, 98 (03) :272-277
[5]  
Global Initiative for Chronic Obstructive Pulmonary Disease, 2006, GLOB STRAT DIAGN TRE
[6]   Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD [J].
Groenewegen, KH ;
Schols, AMWJ ;
Wouters, EFM .
CHEST, 2003, 124 (02) :459-467
[7]   Pharmacoeconomic evaluation of COPD [J].
Hilleman, DE ;
Dewan, N ;
Malesker, M ;
Friedman, M .
CHEST, 2000, 118 (05) :1278-1285
[8]  
Hurd S, 2000, CHEST, V117, P1
[9]   The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991 [J].
Jacobson, L ;
Hertzman, P ;
Löfdahl, CG ;
Skoogh, BE ;
Lindgren, B .
RESPIRATORY MEDICINE, 2000, 94 (03) :247-255
[10]   Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD [J].
Miravitlles, M ;
Murio, C ;
Guerrero, T ;
Gisbert, R .
CHEST, 2002, 121 (05) :1449-1455